1. Home
  2. GMED vs LEU Comparison

GMED vs LEU Comparison

Compare GMED & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • LEU
  • Stock Information
  • Founded
  • GMED 2003
  • LEU 1998
  • Country
  • GMED United States
  • LEU United States
  • Employees
  • GMED N/A
  • LEU N/A
  • Industry
  • GMED Medical/Dental Instruments
  • LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • GMED Health Care
  • LEU Industrials
  • Exchange
  • GMED Nasdaq
  • LEU Nasdaq
  • Market Cap
  • GMED 7.9B
  • LEU 6.9B
  • IPO Year
  • GMED 2012
  • LEU 1998
  • Fundamental
  • Price
  • GMED $62.75
  • LEU $373.00
  • Analyst Decision
  • GMED Buy
  • LEU Buy
  • Analyst Count
  • GMED 14
  • LEU 11
  • Target Price
  • GMED $85.18
  • LEU $194.80
  • AVG Volume (30 Days)
  • GMED 1.3M
  • LEU 1.6M
  • Earning Date
  • GMED 11-06-2025
  • LEU 11-05-2025
  • Dividend Yield
  • GMED N/A
  • LEU N/A
  • EPS Growth
  • GMED 745.36
  • LEU 10.12
  • EPS
  • GMED 2.57
  • LEU 6.16
  • Revenue
  • GMED $2,626,461,000.00
  • LEU $436,900,000.00
  • Revenue This Year
  • GMED $15.62
  • LEU $5.27
  • Revenue Next Year
  • GMED $8.00
  • LEU $9.08
  • P/E Ratio
  • GMED $24.39
  • LEU $59.09
  • Revenue Growth
  • GMED 17.43
  • LEU 12.72
  • 52 Week Low
  • GMED $51.79
  • LEU $49.40
  • 52 Week High
  • GMED $94.93
  • LEU $464.25
  • Technical
  • Relative Strength Index (RSI)
  • GMED 62.38
  • LEU 55.17
  • Support Level
  • GMED $61.50
  • LEU $350.60
  • Resistance Level
  • GMED $63.98
  • LEU $391.80
  • Average True Range (ATR)
  • GMED 1.60
  • LEU 40.93
  • MACD
  • GMED 0.42
  • LEU -7.54
  • Stochastic Oscillator
  • GMED 79.87
  • LEU 46.53

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About LEU Centrus Energy Corp.

Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.

Share on Social Networks: